| scholarly article | Q13442814 |
| P2093 | author name string | Dan Liu | |
| Xiang-Dong Gao | |||
| Xiu-Jun Li | |||
| Ming You | |||
| Huan Dou | |||
| Wen-Bing Yao | |||
| Ya-Yi Hou | |||
| Guang-Feng Zhao | |||
| Yu-Xian Song | |||
| P2860 | cites work | MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis | Q36229458 |
| Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer. | Q36600997 | ||
| Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis | Q37200858 | ||
| Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach | Q37233354 | ||
| Immunodesign of experimental sepsis by cecal ligation and puncture | Q37368111 | ||
| Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function | Q37808561 | ||
| Myeloid-derived suppressor cells in the inflammatory bowel diseases | Q38118052 | ||
| Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis/Septic Shock | Q39779016 | ||
| Protective effect of beta-glucan on lung injury after cecal ligation and puncture in rats. | Q40432076 | ||
| Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. | Q40605195 | ||
| Immature myeloid Gr-1+ CD11b+ cells from lipopolysaccharide-immunosuppressed mice acquire inhibitory activity in the bone marrow and migrate to lymph nodes to exert their suppressive function | Q40904585 | ||
| Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis | Q41718876 | ||
| A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases | Q42210487 | ||
| Editorial: the contribution of myeloid-derived suppression to inflammatory disease | Q42361557 | ||
| Immunological response to (1,4)-alpha-D-glucan in the lung and spleen of endotoxin-stimulated juvenile rats. | Q44765955 | ||
| β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells. | Q45801273 | ||
| Purification, characterization and enzymatic degradation of YCP, a polysaccharide from marine filamentous fungus Phoma herbarum YS4108. | Q46483851 | ||
| Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation | Q46662797 | ||
| Progesterone enhances immunoregulatory activity of human mesenchymal stem cells via PGE2 and IL-6. | Q46757921 | ||
| CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress | Q46925832 | ||
| Myeloid-derived suppressor cells control microbial sepsis | Q48165805 | ||
| Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. | Q54421148 | ||
| Oral and systemic administration of beta-glucan protects against lipopolysaccharide-induced shock and organ injury in rats | Q79913084 | ||
| Pharmacokinetics of fungal (1-3)-beta-D-glucans following intravenous administration in rats | Q80335566 | ||
| "Merinoff symposium 2010: sepsis"-speaking with one voice | Q24595002 | ||
| Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein | Q24641894 | ||
| Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 | ||
| Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy | Q28082461 | ||
| Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
| Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock | Q28244377 | ||
| S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products | Q28276090 | ||
| The epidemiology of sepsis in the United States from 1979 through 2000 | Q29547760 | ||
| The pathophysiology and treatment of sepsis | Q29619103 | ||
| Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis | Q33217018 | ||
| Macrophage receptors of polysaccharide isolated from a marine filamentous fungus Phoma herbarum YS4108. | Q33477866 | ||
| Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy | Q33828888 | ||
| Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. | Q33979918 | ||
| Normal responses to injury prevent systemic inflammation and can be immunosuppressive | Q34141225 | ||
| MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis | Q34298403 | ||
| Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway | Q34314210 | ||
| The effect of age on the development and outcome of adult sepsis | Q34479183 | ||
| Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. | Q34535214 | ||
| Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge | Q34558787 | ||
| Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony | Q34585151 | ||
| Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients | Q34599210 | ||
| Sepsis definitions: time for change | Q34649118 | ||
| Toll-like receptor 2 and Toll-like receptor 4-dependent activation of B cells by a polysaccharide from marine fungus Phoma herbarum YS4108 | Q34654099 | ||
| A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma | Q34699543 | ||
| Immunomodulatory effects of polysaccharide from marine fungus Phoma herbarum YS4108 on T cells and dendritic cells. | Q34707229 | ||
| Preparation and immunomodulating activities of a library of low-molecular-weight α-glucans. | Q35209043 | ||
| Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression | Q35478848 | ||
| Fungal β-Glucans and Mammalian Immunity | Q35538040 | ||
| A genomic storm in critically injured humans | Q35627656 | ||
| Immunosuppression in patients who die of sepsis and multiple organ failure | Q35991015 | ||
| Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response | Q36018144 | ||
| Particulate β-glucan regulates the immunosuppression of granulocytic myeloid-derived suppressor cells by inhibiting NFIA expression | Q36060257 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 1269-1281 | |
| P577 | publication date | 2017-06-26 | |
| P1433 | published in | Acta Pharmacologica Sinica | Q15749885 |
| P1476 | title | The novel α-glucan YCP improves the survival rates and symptoms in septic mice by regulating myeloid-derived suppressor cells. | |
| P478 | volume | 38 |
| Q92132610 | Development of a Bioinformatics Framework for Identification and Validation of Genomic Biomarkers and Key Immunopathology Processes and Controllers in Infectious and Non-infectious Severe Inflammatory Response Syndrome | cites work | P2860 |
Search more.